CSIMarket Company Name, Ticker, Customers, else..
 
Charles River Laboratories International inc   (CRL)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Charles River Laboratories International Inc Income Statement Quarterly

CRL


Select the Financial Report:   Period:   Fiscal Year:

New: More CRL's historic Income Statements >>

INCOME STATEMENT
(Quarterly GAAP In millions $)

 (Jun 29 2024)
II. Quarter		 (Mar 30 2024)
I. Quarter		 (Dec 30 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jul 01 2023)
II. Quarter
Revenue From Contract With Customer Excluding Assessed Tax 1,026.12 1,011.56 1,026.62 1,059.94
Revenue From Contract With Customer Excluding Assessed Tax - - - -
Service Revenue - - - -
Product Revenue - - - -
Total Revenue 1,026.12 1,011.56 1,013.48 1,026.62 1,059.94
Cost of Goods and Services Sold 672.40 666.72 564.85 587.56 578.10
Gross Profit 353.71 344.84 448.63 439.06 481.84
Selling, Administration, Marketing 169.79 186.29 197.14 176.11 199.76
Depriciation & Amortization 32.27 32.58 34.02 34.23 34.27
Research & development - - - - -
Asset Impairment Charges - - - - -
Other operatinig exp. /-income 0.00 - 84.54 77.22 82.86
Unusual Expense /-Income - - - - -
Total operating costs including COS 874.47 885.58 880.55 875.12 894.99
Operating income/-loss 151.65 125.98 132.92 151.50 164.95
Other Deductions / - Income
Interest expense - 35.00 33.54 33.74 35.04
Interest income - - - - -
Net interest expense/-income - 35.00 33.54 33.74 35.04
Investment Income, Interest - - - - -
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income -0.77 -8.04 -109.33 4.89 1.24
Interest Expense Nonoperating 32.77 - - - -
Total costs & expenses 906.46 912.55 804.77 913.75 931.27
Income /-loss before income taxes 119.65 99.01 208.71 112.87 128.66
Income taxes expenses/-benefit 25.39 24.53 19.75 24.85 29.22
Income after income taxes 94.26 74.48 188.95 88.02 99.44
Net income/-loss of other equity - - - - 0.00
Income/-loss from cont. Ops. 94.26 74.48 188.95 88.02 99.44
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss 94.26 74.48 188.95 88.02 99.44
Noncontrolling interests 0.18 1.52 1.87 0.63 2.42
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder 89.99 67.33 187.08 87.39 97.02
EBIT 119.65 134.01 242.25 146.62 163.71
EBITD 205.74 219.37 322.76 225.49 241.38
EBITDA 205.74 219.37 322.76 225.49 241.38


Per Share (GAAP Quarterly, in $) (Jun 29 2024)
II. Quarter		 (Mar 30 2024)
I. Quarter		 (Dec 30 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jul 01 2023)
II. Quarter
Basic EPS (excl. extra items) 1.75 1.31 3.65 1.70 1.89
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS 1.75 1.31 3.65 1.70 1.89
Basic shares outstanding (Mill. of Units) 51.55 51.44 51.31 51.28 51.22
   EPS other shares - - - - -
Diluted Net EPS 1.74 1.30 3.62 1.69 1.89
Diluted average shares (Mill. of Units) 51.85 51.84 51.48 51.61 51.47
Dividend per share - - - - -



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com